These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 223286)

  • 1. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
    Wilson G; Miller G
    Virology; 1979 Jun; 95(2):351-8. PubMed ID: 223286
    [No Abstract]   [Full Text] [Related]  

  • 2. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
    Giunta S; Groppa G
    Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus genome in infectious mononucleosis.
    Pagano JS; Huang CH; Huang YT
    Nature; 1976 Oct; 263(5580):787-9. PubMed ID: 186715
    [No Abstract]   [Full Text] [Related]  

  • 4. Superinfection with Epstein-Barr virus of human lymphoid cell lines of different origin.
    Adams A; Klein G
    Nat New Biol; 1973 Apr; 242(121):234-6. PubMed ID: 4349776
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
    Ernberg I; Kallin B; Dillner J
    Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV), lymphocytes and transformation.
    Zeuthen J
    J Cancer Res Clin Oncol; 1983; 106(1):1-11. PubMed ID: 6309856
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus and human malignancy.
    Ziegler JL; Magrath IT; Gerber P; Levine PH
    Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
    Dölken G; Gier A; Finke J; Weitzmann U
    Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
    [No Abstract]   [Full Text] [Related]  

  • 10. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
    Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual persistence of Epstein-Barr viral and type-C viral genomes in nonproducer human lymphoblastoid cells.
    Osato T; Yamamoto K; Mizuno F; Sugawara K; Aya T
    Bibl Haematol; 1975; (40):585-8. PubMed ID: 169826
    [No Abstract]   [Full Text] [Related]  

  • 13. The Epstein-Barr virus (EBV): evidence for EBV strains.
    Menezes J; Leibold W; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):323-30. PubMed ID: 190135
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
    J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Epstein-Barr virus in hybrid cells.
    Tsang KY; Hann WD
    J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in frozen and thawed cells and subcellular fractions of human lymphoblastoid cell lines by means of an 125I-IgG binding assay.
    Brown TD; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):351-6. PubMed ID: 190139
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus-positive Japanese Burkitt lymphoma.
    Miyoshi I; Hiraki S; Tsubota T; Uno J; Nakamura K; Ota T; Hikita T; Hayashi K; Kataoka M; Tanaka T; Kimura I; Sairenji T; Hinuma Y
    Gan; 1978 Jun; 69(3):449-50. PubMed ID: 208908
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.